13D Filing: Versant Venture Capital IV, L.P. and Crispr Therapeutics AG (CRSP)

CUSIP No.   71723F103

13D

1.

Name of Reporting Persons
Versant Side Fund IV, L.P.

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

 o

(b)

 x(1)

3.

SEC Use Only

4.

Source of Funds (See Instructions)
WC

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)     o

6.

Citizenship or Place of Organization
Delaware, United States

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
16,224 shares of common stock (2)

8.

Shared Voting Power
0

9.

Sole Dispositive Power
16,224 shares of common stock (2)

10.

Shared Dispositive Power
0

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
16,224 shares of common stock (2)

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

13.

Percent of Class Represented by Amount in Row 11
0.04% (3)

14.

Type of Reporting Person (See Instructions)
PN